Two Sigma Investments, LP Opiant Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.52 - $13.48 $145,903 - $206,594	-15,326 Reduced 41.36%	21,730 $234,000
Q2 2022 Aug 15, 2022	SELL	$10.12 - $23.32 $17,973 - $41,416	-1,776 Reduced 4.57%	37,056 $444,000
Q1 2022 May 16, 2022	SELL	$19.54 - $33.59 $492,896 - $847,307	-25,225 Reduced 39.38%	38,832 $832,000
Q4 2021 Feb 14, 2022	BUY	$22.51 - $36.79 $292,900 - $478,711	13,012 Added 25.49%	64,057 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$13.28 - $25.79 $677,877 - $1.32 Million	51,045 New	51,045 $1.31 Million

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.